Pharmacia Rogaine
This article was originally published in The Tan Sheet
Executive Summary
Sales for 2000 decline 4% in U.S. and worldwide to $103 mil. and $134 mil., respectively, firm reports Feb. 12. Fourth quarter sales for the hair regrowth formula were $27 mil. domestically and $34 mil. worldwide, falling 7% and 11% from the year-ago quarter. Revenues from U.S. sales of Nicorette totaled $88 mil. for 2000, down 15%, and $218 mil. worldwide, a 7% decline. Total pharmaceutical sales reached $3.34 bil. in the quarter, up 8%, and $12.65 bil. for the year, advancing 14%
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning